Patent ID: 11963947
Assignee: HUA MEDICINE (SHANGHAI) LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 17:
18. The fixed dose combination formulation of claim 1, comprising by weight:
about 75 mg of HMS5552 in a solid dispersion comprising about 1:1 of HMS5552 and Eudragit L100;
about 100 mg of sitagliptin or a corresponding amount of sitagliptin phosphate monohydrate;
about 0-50% of filler(s);
about 2-8% of binder(s);
about 1-5% of disintegrant(s);
about 0.5-3% of lubricant(s); and
about 0-0.5% of glidant(s).